The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

The AI model processes pre-contrast and a single post-contrast T1 image, identifying suspicious regions and assigning a ...

A recent study highlights that lumpectomy, as opposed to mastectomy followed by breast reconstruction, can lead to better sexual well-being for breast cancer patients. Learn more: ...

Investigative Reporter Katie LaGrone shares the personal stories of five Florida women all diagnosed with breast cancer and all denied coverage for care by their insurance companies.

NASHUA, N.H. and TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer ...

It's not the pace of innovation that limits us, but how society harnesses these advances, says Gemma Peters, chief executive of Macmillan ...

Immorta Bio Inc., a leader in longevity-focused biotechnologies, announced today acceptance of its poster presentation at the upcoming Society for Immunotherapy of Cancer (SITC) Spring Scientific, ...

Puma Biotechnology, Inc. , a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will provide an overview of Puma at 2:00 p.m. ET on ...

UK initiative to harness big biological data sets and look deeper into how the human body works and malfunctions ...